Erklärung zur Barrierefreiheit Navigation überspringen
  • Zurück zu Global Sites
  • +44 (0)20 7454 5110
  • DSGVO
  • Journalisten
  • Weitere Informationen anfordern
PR Newswire: news distribution, targeting and monitoring
  • Nachrichten
  • Produkte
  • Kontakt
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Weitere Informationen anfordern
    • Telefon

    • +44 (0)20 7454 5110 von 8 AM - 5 PM GMT

    • Kontakt
    • Kontakt

      +44 (0)20 7454 5110
      von 8 AM - 5 PM GMT

  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO
  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO
  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO
  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO

Nektium's Botanical Ingredient Zynamite® Granted US Patent for Brain Enhancing Activities
  • USA - English
  • Deutschland - Deutsch
  • France - Français


Vom Nachrichtendienst

Nektium

14 Apr, 2020, 07:00 GMT

Artikel teilen

Share toX

Artikel teilen

Share toX

LAS PALMAS, Spain, April 14, 2020 /PRNewswire/ -- Nektium, a leading research-based branded botanical ingredient manufacturer based in Spain, today announced that the United States Patent and Trademark Office has issued the company with a notice of allowance for U.S. Patent 10,537,604 Compositions for Enhancing Brain Activity. This patent is part of the intellectual property portfolio supporting NEKTIUM's innovative ingredient Zynamite®, a caffeine-free botanical ingredient for mental and physical energy. Zynamite® is a sustainable, proprietary standardized extract of leaves of a selection of Mangifera indica, the mango tree.

Continue Reading
Nektium's Botanical Ingredient Zynamite(R) Granted US Patent for Brain Enhancing Activities.
Nektium's Botanical Ingredient Zynamite(R) Granted US Patent for Brain Enhancing Activities.

Zynamite® was first launched at Vitafoods in Geneva and HI Japan in Tokyo in 2018 and at Supply Side West in the USA in 2019. The caffeine-free and doping-free nootropic activities of Zynamite® have been appearing in diverse finished product innovations including popular smart supplements and egaming formulations in Japan.

Recognising the fundamental importance of the mind in sports performance, Nektium applied the brain-activating activities of Zynamite® to sports formulations which have been subjected to four double blind, randomised controlled clinical trials. The positive results of these sports performance and recovery studies have been published in four peer-reviewed papers.

"The currency of the nutraceutical ingredient industry is scientific evidence obtained from double blind, randomised controlled clinical studies conducted by reputable academic departments and CRO's, and published in leading peer-reviewed journals.  Nektium has made a major investment in the clinical research backing Zynamite® and continues to invest in ongoing clinical studies," says Dr. Nigel Gericke, Nektium's Director of Science. "Our intention is to keep building the clinical research base and intellectual property supporting Zynamite® as a premium branded ingredient."

The nutraceutical industry has already recognized the clinical research and innovation behind Zynamite® awarding the ingredient five awards in the last two years: the Nutraingredients Award for sports ingredient of the year in 2018, the Nutraingredients Award for research in 2019, the Frost & Sullivan Award for innovation in 2019, and the European Specialised Sports Nutrition Awards for the 2019 best 'free from' ingredient, and the 2019 runner up award for game changer ingredient of the year.

About Nektium

Nektium is an innovative botanical ingredients company that discovers, develops and commercializes science-based natural ingredients through close integration of the departments of R&D, production and Quality Assurance. The company provides seamless research-based solutions to the nutraceutical industry. Nektium´s ingredient portfolio includes branded ingredients and standardized extracts.  To learn more about Nektium, visit www.nektium.com

Photo - https://mma.prnewswire.com/media/1154455/Nektium_Zynamite_Patent.jpg

Nektium Media Contact:
Nektium Pharma S.L.
Deborah Thoma  
[email protected]

Weitere Links

http://www.nektium.com

Modal title

Kontaktaufnahme zu PR Newswire

  • +44 (0)20 7454 5110
    von 8 AM - 5 PM GMT

Globale Seiten

  • APAC
  • APAC - Traditional Chinese
  • Asien
  • Brasilien
  • Kanada
  • Tschechische Republik
  • Dänemark
  • Finnland
  • Frankreich
  • Deutschland

 

  • Indien
  • Indonesia
  • Israel
  • Italien
  • Mexiko
  • Naher Osten
  • Middle East - Arabic
  • Niederlande
  • Norwegen
  • Polen

 

  • Portugal
  • Russland
  • Slowakei
  • Spanien
  • Schweden
  • Großbritannien
  • Vereinigte Staaten

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Globale Seiten
  • Asien
  • Brasilien
  • Kanada
  • Tschechische Republik
  • Dänemark
  • Finnland
  • Frankreich
  • Deutschland
  • Indien
  • Israel
  • Italien
  • Mexiko
  • Naher Osten
  • Niederlande
  • Norwegen
  • Polen
  • Portugal
  • Russland
  • Slowakei
  • Spanien
  • Schweden
  • Großbritannien
  • Vereinigte Staaten
+44 (0)20 7454 5110
von 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.